ArQule announces presentations on ARQ 197 c-Met inhibitor at 2010 ASCO ArQule cialis generic.

ArQule announces presentations on ARQ 197 c-Met inhibitor at 2010 ASCO ArQule, Inc. today announced that the following presentations of clinical data for ARQ 197, a selective inhibitor of the c-Met receptor tyrosine kinase, will need place at the 2010 American Society of Clinical Oncology Annual Meeting, june 4-8 which is kept, 2010 in Chicago, Illinois. The symposium will need place on Saturday, June 5, 2010 from 8:00 AM – 9:30 AM, with the presentation period scheduled to begin at 9:00 AM cialis generic . Note: that is a late-breaking abstract submission, on June 5 the embargo for which will be lifted, 2010.M. – 6:00 P.

Approximately 100, 000 people in Flanders now have dementia. In 2020 this number increase to 130, 000 and in 2050 it shall be 200,000. Despite intense efforts and years of analysis there is currently no curative treatment. Even a treatment that decreases the condition is not immediately available significantly.. In the prestigious journal Cell, the Alzheimer's professional Bart De Strooper argues these studies aren’t pointless, but merely indicate what the next steps should be for the Alzheimer's research. This content – or rather, this message – will be pass on at the biggest Neuroscience meeting that may take place mid-November in Washington. Bart De Strooper: ‘We need to learn from Helps, cholesterol or cancer research: we can only look for a drug to treat Alzheimer's disease if we are prepared to learn from the down sides that we encounter.

Other Posts From Category "rehabilitation":

Related Posts